Your browser doesn't support javascript.
loading
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
Guenther, Michael; Surendran, Sai Agash; Haas, Michael; Heinemann, Volker; von Bergwelt-Baildon, Michael; Engel, Jutta; Werner, Jens; Boeck, Stefan; Ormanns, Steffen.
Afiliação
  • Guenther M; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany.
  • Surendran SA; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.
  • Haas M; Institute of Pathology, Faculty of Medicine, Ludwig-Maximilians-University, Munich, Germany.
  • Heinemann V; Department of Internal Medicine III, Grosshadern University Hospital, Ludwig-Maximilians-University, Munich, Germany.
  • von Bergwelt-Baildon M; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.
  • Engel J; Department of Internal Medicine III, Grosshadern University Hospital, Ludwig-Maximilians-University, Munich, Germany.
  • Werner J; German Cancer Consortium (DKTK), Partner Site, Munich, Germany.
  • Boeck S; Department of Internal Medicine III, Grosshadern University Hospital, Ludwig-Maximilians-University, Munich, Germany.
  • Ormanns S; Munich Cancer Registry (MCR), Munich Tumor Centre (TZM), Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany.
Br J Cancer ; 129(1): 175-182, 2023 07.
Article em En | MEDLINE | ID: mdl-37142730

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article